This article requires a subscription to view the full text. You may purchase access to this article or login to access your subscription using the links below.
Abstract
KRASG12C-mutant cells treated with KRASG12C inhibitors quickly became either quiescent or resistant.
- ©2020 American Association for Cancer Research.
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
March 2020
Volume 10, Issue 3
Volume 10, Issue 3
Newly Synthesized KRASG12C Mediates Escape from KRASG12C Inhibition
Jump to section
Advertisement